Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210964508> ?p ?o ?g. }
- W4210964508 abstract "Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, so there is an urgent need to suppress its development at early stage. Shenkang pills (SKP) are a hospital prescription selected and optimized from effective traditional Chinese medicinal formulas for clinical treatment of DN. In the present study, liquid chromatography-quadrupole-time of flight-mass spectrometry (LC-Q-TOF-MS) and total contents qualification were applied to generate a quality control standard of SKP. For verifying the therapeutic effects of SKP, db/db mice were administered intragastrically with SKP at a human-equivalent dose (1.82 g/kg) for 4 weeks. Moreover, the underlying mechanism of SKP were analyzed by the renal RNA sequencing and network pharmacology. LC-Q-TOF-MS identified 46 compounds in SKP. The total polysaccharide and organic acid content in SKP were 4.60 and 0.11 mg/ml, respectively, while the total flavonoid, saponin, and protein content were 0.25, 0.31, and 0.42 mg/ml, respectively. Treatment of SKP significantly reduced fasting blood glucose, improved renal function, and ameliorated glomerulosclerosis and focal foot processes effacement in db/db mice. In addition, SKP protected podocytes from injury by increasing nephrin and podocin expression. Furthermore, transcriptome analyses revealed that 430 and 288 genes were up and down-regulated in mice treated with SKP, relative to untreated controls. Gene ontology enrichment analysis revealed that the differentially expressed genes mainly involved in modulation of cell division and chromosome segregation. Weighted gene co-expression network analysis and network pharmacology analysis indicated that aurora kinase B (AURKB), Rac GTPase activating protein 1 (RacGAP1) and SHC binding, and spindle associated 1 (shcbp1) might be the core targets of SKP. This protein and Ras homolog family member A (RhoA) were found overexpression in db/db mice, but significantly decreased with SKP treatment. We conclude that SKP can effectively treat early-stage DN and improve renal podocyte dysfunction. The mechanism may involve down-regulation of the AURKB/RacGAP1/RhoA pathway." @default.
- W4210964508 created "2022-02-13" @default.
- W4210964508 creator A5001191342 @default.
- W4210964508 creator A5004149893 @default.
- W4210964508 creator A5006682672 @default.
- W4210964508 creator A5012870141 @default.
- W4210964508 creator A5014463358 @default.
- W4210964508 creator A5050655927 @default.
- W4210964508 creator A5053278768 @default.
- W4210964508 creator A5077182809 @default.
- W4210964508 creator A5078395205 @default.
- W4210964508 date "2022-02-11" @default.
- W4210964508 modified "2023-10-01" @default.
- W4210964508 title "Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway" @default.
- W4210964508 cites W1487257968 @default.
- W4210964508 cites W1847884533 @default.
- W4210964508 cites W1890471463 @default.
- W4210964508 cites W1971552689 @default.
- W4210964508 cites W1998740840 @default.
- W4210964508 cites W1999574084 @default.
- W4210964508 cites W2004558827 @default.
- W4210964508 cites W2008864584 @default.
- W4210964508 cites W2024482135 @default.
- W4210964508 cites W2027718126 @default.
- W4210964508 cites W2057259387 @default.
- W4210964508 cites W2059946666 @default.
- W4210964508 cites W2061849818 @default.
- W4210964508 cites W2097300515 @default.
- W4210964508 cites W2101197058 @default.
- W4210964508 cites W2102278945 @default.
- W4210964508 cites W2104005232 @default.
- W4210964508 cites W2113664327 @default.
- W4210964508 cites W2128877622 @default.
- W4210964508 cites W2133992677 @default.
- W4210964508 cites W2135436234 @default.
- W4210964508 cites W2145027776 @default.
- W4210964508 cites W2155574603 @default.
- W4210964508 cites W2157373537 @default.
- W4210964508 cites W2159891842 @default.
- W4210964508 cites W2163543028 @default.
- W4210964508 cites W2167382061 @default.
- W4210964508 cites W2168287443 @default.
- W4210964508 cites W2179438025 @default.
- W4210964508 cites W2265482926 @default.
- W4210964508 cites W2290466312 @default.
- W4210964508 cites W2325141302 @default.
- W4210964508 cites W2512377627 @default.
- W4210964508 cites W2568281416 @default.
- W4210964508 cites W2585352231 @default.
- W4210964508 cites W2592968469 @default.
- W4210964508 cites W2660179161 @default.
- W4210964508 cites W2729363294 @default.
- W4210964508 cites W2735518797 @default.
- W4210964508 cites W2773858809 @default.
- W4210964508 cites W2789449353 @default.
- W4210964508 cites W2791645463 @default.
- W4210964508 cites W2896399980 @default.
- W4210964508 cites W2900624820 @default.
- W4210964508 cites W2902632975 @default.
- W4210964508 cites W2904403202 @default.
- W4210964508 cites W2909517991 @default.
- W4210964508 cites W2911512511 @default.
- W4210964508 cites W2914534851 @default.
- W4210964508 cites W2915700009 @default.
- W4210964508 cites W2937830908 @default.
- W4210964508 cites W2944325943 @default.
- W4210964508 cites W2950572042 @default.
- W4210964508 cites W2968872427 @default.
- W4210964508 cites W2969577190 @default.
- W4210964508 cites W2974281380 @default.
- W4210964508 cites W2977880419 @default.
- W4210964508 cites W2981176414 @default.
- W4210964508 cites W2989340312 @default.
- W4210964508 cites W2996172831 @default.
- W4210964508 cites W3000914754 @default.
- W4210964508 cites W3016750987 @default.
- W4210964508 cites W3019537017 @default.
- W4210964508 cites W3029601476 @default.
- W4210964508 cites W3043287600 @default.
- W4210964508 cites W3047697143 @default.
- W4210964508 cites W3076963421 @default.
- W4210964508 cites W3087420469 @default.
- W4210964508 cites W3096728658 @default.
- W4210964508 cites W3119063206 @default.
- W4210964508 cites W3138247269 @default.
- W4210964508 cites W3194840276 @default.
- W4210964508 cites W4211122976 @default.
- W4210964508 cites W4482768 @default.
- W4210964508 doi "https://doi.org/10.3389/fphar.2022.781806" @default.
- W4210964508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35222021" @default.
- W4210964508 hasPublicationYear "2022" @default.
- W4210964508 type Work @default.
- W4210964508 citedByCount "4" @default.
- W4210964508 countsByYear W42109645082022 @default.
- W4210964508 countsByYear W42109645082023 @default.
- W4210964508 crossrefType "journal-article" @default.
- W4210964508 hasAuthorship W4210964508A5001191342 @default.
- W4210964508 hasAuthorship W4210964508A5004149893 @default.
- W4210964508 hasAuthorship W4210964508A5006682672 @default.
- W4210964508 hasAuthorship W4210964508A5012870141 @default.